Archives
-
EdU Imaging Kits (HF594) for Treg Proliferation
2026-09-12
EdU Imaging Kits (HF594) provide an antibody-free way to quantify S-phase DNA synthesis while preserving cell morphology and antigen accessibility. This makes the assay especially useful for separating Treg expansion from differentiation in asthma studies, as well as for microscopy, flow cytometry, genotoxicity, and pharmacodynamic workflows.
-
Isoprinosine in HSV-1 Research: Workflows & Tips
2026-09-11
Isoprinosine, also called inosine pranobex, supports a practical two-axis strategy: measure antiviral activity while tracking host-cell and immune-state effects. This guide connects exploratory Isoprinosine assays with the newly identified CLCC1-dependent herpesvirus nuclear-egress pathway without overstating a direct molecular interaction.
-
Hoechst 33342: Reliable Nuclear Staining
2026-09-11
This scenario-driven guide explains how Hoechst 33342 supports orthogonal cell counting, live and fixed-cell imaging, and flow cytometry workflows. It also provides practical selection and handling guidance for Hoechst 33342 Solution (1 mg/mL), SKU K2407.
-
I-BET-762: An Assay-First Guide to BET Biology
2026-09-10
I-BET-762 is a selective BET inhibitor for dissecting chromatin-dependent transcription, inflammation, and ferroptosis. This assay-first guide explains how to connect target engagement with ROS, FSP1, and LPS-responsive phenotypes while avoiding overinterpretation.
-
pH-Sensitive Nanoparticles and Breast Cancer Resistance
2026-09-10
The reference study developed SchB/AP nanoparticles designed to co-deliver all-trans retinoic acid and schisandrin B to drug-resistant breast cancer stem cells. Its in vitro findings connect pH-responsive release, lysosomal escape, P-glycoprotein suppression, and altered energy support for drug efflux, while also highlighting the limits of translating cell-based results to in vivo therapy.
-
BCECF-AM for Plant Autophagy pH Mapping
2026-09-09
Use BCECF-AM to convert intracellular acid–base changes into quantitative ratiometric data while investigating SINAT–VAB1 control of autophagic vesicle degradation in Arabidopsis. This workflow emphasizes live-cell imaging, genotype-aware controls, and troubleshooting for plant tissues where vacuolar acidification and cytosolic pH can diverge.
-
Nurr1 Neurons and Claustrum Development in Rats
2026-09-09
Fang, Wang, and Naumann mapped the developmental emergence of Nurr1-positive neurons in the rat claustrum and lateral cortex and resolved their birth-dating patterns with combined EdU labeling and Nurr1 in situ hybridization. The study identifies sequential neurogenesis and regional gradients that refine how claustrum-related structures are defined during embryonic development.
-
DAPI Nuclear Stain Solution: Practical Protocol
2026-09-08
DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution, SKU K2402, provides a pre-diluted fluorescent DNA binding dye for nuclear visualization, cell viability assessment, and apoptosis-related nuclear evaluation. It is most appropriate for fixed or membrane-compromised samples analyzed by fluorescence microscopy or flow cytometry, rather than routine imaging of intact live cells.
-
OCT2/MATE1 Inhibition by Antiemetic Drugs
2026-09-08
George and colleagues evaluated how five 5-HT3 receptor antagonist drugs affect the renal organic-cation transporters OCT2 and MATE1. Their cell-based experiments identify marked compound-specific differences in transporter inhibition and show why antiemetic therapy can be relevant to serotonin receptor signaling research, renal drug disposition, and potential transporter-mediated interactions.
-
CPSIT_0844 Drives IL-6 and IL-8 via TLR2/4
2026-09-07
The reference study identifies the Chlamydia psittaci inclusion membrane protein CPSIT_0844 as a proinflammatory factor that induces IL-6 and IL-8 in human monocytes. Its perturbation experiments connect CPSIT_0844 to a TLR2/TLR4–MyD88 axis and downstream JNK, p38, and NF-κB signaling, providing a mechanistic framework for C. psittaci-associated inflammation.
-
Tβ4, Notch/NF-κB, and Limb Ischemia Angiogenesis
2026-09-07
The reference study links thymosin-β4 overexpression with enhanced endothelial viability, migration, and angiogenic behavior in vitro and improved vascular remodeling markers in a mouse model of critical limb ischemia. Its key contribution is the proposed connection between these effects and coordinated Notch/NF-κB pathway activity, while pharmacological inhibition experiments provide mechanistic support without establishing direct molecular binding.
-
PINK1/Park2 Mitophagy in Fatty Liver Disease
2026-09-05
The reference study links Park2-mediated mitophagy with reduced lipid-associated mitochondrial injury in an oleic-acid cellular model of non-alcoholic fatty liver disease. By combining Park2 overexpression and knockdown with imaging, biochemical, inflammatory, and molecular readouts, it provides a mechanistic basis for further investigation while remaining limited by its in vitro design.
-
Phebestin Reveals a New Antiplasmodial Strategy
2026-09-04
The reference study identifies phebestin, a bestatin-related aminopeptidase inhibitor, as a nanomolar inhibitor of Plasmodium falciparum growth with activity against both chloroquine-sensitive and chloroquine-resistant parasites. By combining phenotypic assays, stage-specific testing, molecular modeling, and mouse infection studies, the work supports parasite metalloaminopeptidases as tractable targets for antimalarial discovery while also defining important translational limitations.
-
EdU Imaging Kits (HF594): 5 Practical Scenarios
2026-09-04
This scenario-based guide explains how EdU Imaging Kits (HF594), SKU K2243, support DNA synthesis measurement in fluorescence microscopy and flow cytometry. It addresses assay design, compatibility, optimization, interpretation, and practical vendor-selection criteria without equating EdU incorporation with viability or completed cell division.
-
Verteporfin Activates IRE1α to Enhance AKT Inhibition
2026-09-03
A 2025 Cell Chemical Biology study identifies verteporfin as a molecular glue-like activator of IRE1α, promoting its dimerization through a mechanism involving His692. The resulting IRE1α–XBP1–miR-153 pathway links endoplasmic reticulum stress signaling to PTEN loss, AKT activation, and BACH1 suppression, while combined AKT inhibition strengthens antitumor activity in breast cancer models.